Shanghai Runda Medical Technology Co

Shanghai Runda Medical Technology Co Net Debt/Equity

The Net Debt to Equity Ratio of Shanghai Runda Medical Technology Co (603108.SS) as of Oct 27, 2026 is 0.17. In the previous year, Net Debt to Equity Ratio was 1.06 — a change of -84.17% (lower).

Net Debt/Equity

0.17

YoY

-84.17%

Last updated:

Net Debt to Equity Ratio of Shanghai Runda Medical Technology Co is 2025 0.17 . Net Debt to Equity Ratio of Shanghai Runda Medical Technology Co was 2024 1.06 . It decreases by -84.17% lower compared to the previous year.

The Shanghai Runda Medical Technology Co Net Debt/Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt/Equity
Date
Net Debt/Equity
Jan 1, 2018
0.82 CNY
Jan 1, 2019
0.76 CNY
Jan 1, 2020
1.09 CNY
Jan 1, 2021
1.34 CNY
Jan 1, 2022
1.48 CNY
Jan 1, 2023
1.34 CNY
Jan 1, 2024
1.06 CNY
Jan 1, 2025
0.17 CNY
The Shanghai Runda Medical Technology Co Net Debt/Equity history
YEARNet Debt/EquityYoY
0.17-84.17%
1.06-21.07%
1.34-9.56%
1.48+10.38%
1.34+23.05%
1.09+42.35%
0.76-6.50%
0.82-22.50%
1.06+499.92%
0.18-54.66%
0.39+0.38%
0.39—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Shanghai Runda Medical Technology Co Stock analysis

What does Shanghai Runda Medical Technology Co do? Shanghai Runda Medical Technology Co., Ltd. generates revenue through the wholesale distribution of surgical and medical instruments, apparatus, and equipment within the domestic market. The company offers integrated services including product portfolio options, professional application services, logistics warehousing distribution systems, and technical support. Its customers include healthcare providers and medical institutions that require surgical tools and equipment. The firm's business model focuses on domestic sales with a workforce of 3,499 full-time employees managing these operations. The company's primary revenue streams come from the distribution of medical instruments and equipment, supported by its comprehensive service offerings. It provides sales support and customer channel management to facilitate transactions with its clients. The firm's domestic market focus ensures that its services are tailored to the needs of Chinese healthcare facilities and institutions. Shanghai Runda's business is structured around the wholesale distribution of medical products, with additional value-added services such as technical support and logistics management. The company's integrated approach combines product distribution with application services, enhancing its market position in the domestic healthcare sector. Shanghai Runda Medical Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shanghai Runda Medical Technology Co stock

Net Debt to Equity Ratio of Shanghai Runda Medical Technology Co is 0.17 in 2025.

Net Debt to Equity Ratio of Shanghai Runda Medical Technology Co changed from 1.06 to 0.17, representing a -84.17% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Debt to Equity Ratio Shanghai Runda Medical Technology Co since 2006 – with annual values, charts, and detailed analysis.

Net Debt/Equity adjusts the debt-to-equity ratio by subtracting cash from total debt. It provides a more accurate picture of actual leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to Equity Ratio's Shanghai Runda Medical Technology Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Shanghai Runda Medical Technology Co

All Key Metrics — Shanghai Runda Medical Technology Co